Abstract P5-14-01: A meta-analysis of clinical benefit rates for fulvestrant 500 mg versus alternative therapies for treatment of postmenopausal, estrogen receptor-positive advanced breast cancer Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Robertson, JFR
  • Zefei, J
  • Di Leo, A
  • Ohno, S
  • Pritchard, Kathleen
  • Ellis, M
  • Bradbury, I
  • Campbell, C

publication date

  • February 15, 2016